An observational study (IC-SOHO) comparing olanzapine, risperidone, quetiapine, and haloperidol in the treatment of patients with schizophrenia:: 12-month results

被引：0

作者：

Treuer, T

Bartiene, R

Blinc-Pesek, M

Grigoriu, A

Herman, E

Molnár, B

Pecenak, J

Shakhnovich, T

Szulc, A

Leadbetter, J

O'Mahoney, J

机构：

[1] Eli Lilly GesmbH, Clin Res Neurosci, Vienna, Austria

[2] Seskines Mental Hlth Ctr, Dept Psychiat, Vilnius, Lithuania

[3] Psichiatricna Klin Polje, Dept Psychiat, Ljubljana, Slovenia

[4] Hosp Neurol & Psychiat, Dept Psychiat, Brasov, Romania

[5] Psychiat Outpatient Clin, Dept Psychiat, Szeghalom, Hungary

[6] Univ Hosp Bratislava, Dept Psychiat, Bratislava, Slovakia

[7] Psychiat Hosp N4, Dept Psychiat, Moscow, Russia

[8] Med Acad, Dept Psychiat, Choroszcz, Poland

[9] Eli Lilly Australia Pty Ltd, Clin Outcomes & Res Inst, Sydney, NSW, Australia

来源：

关键词：

D O I：

10.1016/S0924-977X(04)80309-2

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S271 / S272

页数：2